DIABILIVE
LIVE

Serial Number

79236421

Owner

MirambeauAppCare

Attorney

Judith A. Keene

Filing Date

Feb 27, 2018

Add to watchlist:

No watchlists yet
View on USPTO

DIABILIVE Trademark

Serial Number: 79236421 • Registration: 5688304

DIABILIVE is a trademark filed by MirambeauAppCare on February 27, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

MirambeauAppCare

Technopole Montesquieu
F-33650 Martillac , FR

Entity Type: 34

Trademark Details

Filing Date

February 27, 2018

Registration Date

March 5, 2019

Published for Opposition

December 18, 2018

Cancellation Date

September 19, 2025

Goods & Services

Scientific and technological services, namely, scientific research in the field of testing and managing blood glucose, carbohydrate intake, calorie intake, calculating and managing insulin dosage, and physical activity levels, and providing related reports and alerts; design and development of computers and software; development of computer hardware; design and development of software in the field of mobile applications; information technology (IT) consultancy; engineering in the field of medical equipment; software as a service (SAAS) services featuring software for testing and managing blood glucose, carbohydrate intake, and calorie intake, calculating and managing insulin dosage, and physical activity levels, and providing related reports and alerts; research and development of new products; programming of computers for others; software consultancy; design, development, programming, and implementation of software; rental of software; maintenance of software; cloud hosting provider services; electronic data storage; hosting the websites of others on a computer server for a global computer network; providing search engines containing medical information

Medical, surgical, dental, and veterinary apparatus and instruments, namely, glucometers, blood pressure monitors, oximeters, and thermometers to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; electronic apparatus for medical use, namely, glucometers, blood pressure monitors, oximeters, and thermometers to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; diagnostic apparatus for medical use, namely, glucometers, blood pressure monitors, oximeters, and thermometers; analysis apparatus for medical use, namely, glucometers, blood pressure monitors, oximeters, and thermometers; automatic analyzers for medical diagnosis, namely, glucometers, blood pressure monitors, oximeters, and thermometers; blood glucose monitors; blood testing apparatus for medical use

Telecommunications, namely, video conferencing; provision of access to databases; provision of access to online databases; communication by electronic computer terminals; rental of message sending apparatus, namely, smartphones, medical data readers, and personal computers; transmission of digital files; computer-aided transmission of messages and images; provision of access to platforms and portals on the Internet relating to health, medicine, and wellness

Medical services; medical testing for diagnostic or treatment purposes in the field of diabetes, hypoglycemia, and hyperglycemia; providing an Internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the website that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; home health care services; advisory services relating to health and medical care; providing medical and health information and providing healthcare consulting; information relating to health, namely, testing and managing blood glucose, carbohydrate intake, calorie intake, calculating and managing insulin dosage, physical activity levels, and related reports; medical analysis services in the field of diabetes, hypoglycemia, and hyperglycemia; medical assistance

Scientific, photographic, optical, weighing, and measuring apparatus and instruments, namely, smart watches, weighing scales, thermometers, global positioning system (GPS) apparatus, hydrometers, and height gauges to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; apparatus for recording, transmission, or reproduction of sound or images; magnetic recording media, sound recording disks, compact disks, dvds, and other digital recording media, namely, USB keys containing medical data and health reports; data processing apparatus; computers; software to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; computer programs, namely, software to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate insulin dosage, and to provide related reports and alerts; computer application software for mobile phones to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; downloadable mobile applications for portable computer devices, namely, software to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; downloadable software for data management namely, software to manage data derived from testing and managing blood glucose, carbohydrate intake, calorie intake, calculating and managing insulin dosage, physical activity levels, and related reports; electronic databases to maintain information regarding blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, all recorded on computer media; downloadable image files containing imagery relating to blood glucose, carbohydrate intake, calorie intake, and physical activity; downloadable cloud software, namely, software to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; cloud network servers

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 19, 2026 INTR
CANCELLED SECTION 71
Sep 19, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 5, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 16, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 19, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 28, 2019 FICS
FINAL DISPOSITION PROCESSED
Jun 28, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 5, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 5, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 18, 2018 NPUB
PUBLISHED FOR OPPOSITION
Dec 18, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Dec 15, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 28, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 28, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 28, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 15, 2018 PREV
ASSIGNED TO LIE
Nov 12, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 30, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 30, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 30, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 30, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 30, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 12, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 11, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 11, 2018 TROA
REFUSAL PROCESSED BY IB
Aug 31, 2018 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 16, 2018 RFCS
REFUSAL PROCESSED BY MPU
Aug 16, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 3, 2018 RFCR
NON-FINAL ACTION WRITTEN
Aug 2, 2018 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Aug 2, 2018 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 18, 2018 RFCR
APPLICATION FILING RECEIPT MAILED
Jul 18, 2018 MAFR
NON-FINAL ACTION WRITTEN
Jul 17, 2018 CNRT
ASSIGNED TO EXAMINER
Jul 15, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 12, 2018 REPR